Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc. | 10%+ Owner | Common Stock | 3.22M | $19.2M | $5.97 | Feb 14, 2023 | Direct |
IO Biotech, Inc. | 10%+ Owner | Common Stock | 2.69M | $2.78M | $1.04 | Nov 9, 2021 | Direct |
IO Biotech, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | Nov 9, 2021 | Direct | ||
Mineralys Therapeutics, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Feb 14, 2023 | Direct | ||
Mineralys Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Feb 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MLYS | Mineralys Therapeutics, Inc. | Feb 14, 2023 | 5 | $5M | 4 | Feb 16, 2023 | 10%+ Owner |
MLYS | Mineralys Therapeutics, Inc. | Feb 9, 2023 | 0 | $0 | 3 | Feb 9, 2023 | 10%+ Owner |
IOBT | IO Biotech, Inc. | Nov 9, 2021 | 3 | $4.55M | 4 | Nov 12, 2021 | 10%+ Owner |
IOBT | IO Biotech, Inc. | Nov 4, 2021 | 0 | $0 | 3 | Nov 4, 2021 | 10%+ Owner |